Company Update Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Alembic Pharmaceuticals receives USFDA Final approval for Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg and 400 mg